Attached files

file filename
10-Q - Tanke Biosciences Corpe609698_10q-tanke.htm
EX-31.2 - Tanke Biosciences Corpe609698_ex31-2.htm
EX-32.1 - Tanke Biosciences Corpe609698_ex32-1.htm
EX-31.1 - Tanke Biosciences Corpe609698_ex31-1.htm
EXCEL - IDEA: XBRL DOCUMENT - Tanke Biosciences CorpFinancial_Report.xls
Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the accompanying Quarterly Report on Form 10-Q of Tanke Biosciences Corporation for the period ended March 31, 2012, I, Gilbert Kwong-Yiu Lee, Chief Financial Officer of Tanke Biosciences Corporation, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
 
1.
Such Quarterly Report on Form 10-Q for the period ended March 31, 2012, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
The information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2012, fairly represents in all material respects, the financial condition and results of operations of Tanke Biosciences Corporation.

 
Dated: May 17, 2012
 /s/ Gilbert Kwong-Yiu Lee
 
Gilbert Kwong-Yiu Lee
 
Chief Financial Officer
(Principal Financial Officer)